Literature DB >> 7667230

[Lung metastases from colorectal cancer: results of surgery].

P Girard1, P Baldeyrou, D Grunenwald.   

Abstract

OBJECTIVES: Surgery has become a recognized therapeutic means in selected patients with isolated pulmonary metastases, with a 5-year survival rate of about 35%, but specific studies on the results and prognosis of surgery for pulmonary metastases from colorectal cancer remain relatively rare.
METHODS: Between 1980 and 1991, 65 patients (34 men, 31 women, mean age 58.2 years) underwent 81 thoracic operations with curative intent (including 15 bilateral operations and 7 incomplete resections) for pulmonary metastases from colorectal cancer.
RESULTS: The 5- and 10-year probabilities of survival (Kaplan-Meier) after the first thoracic operation were 27% and 22% respectively. The site of the primary tumor (colon or rectum), the disease-free interval, previous resection(s) of hepatic metastases, and the size of pulmonary metastases were not found to the have a statistically significant influence on prognosis. On the other hand, the quality of resection (complete or incomplete) (p < 0.001), the number of resected pulmonary metastases (p = 0.016), and the preoperative carcino-embryonic antigen level (p < 0.001) were found to be highly significant prognostic factors.
CONCLUSION: Complete resection of pulmonary metastases from colorectal cancer seems to prolong survival in a significant number of patients, and the results from this study should help to select those who may benefit from this treatment.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7667230

Source DB:  PubMed          Journal:  Presse Med        ISSN: 0755-4982            Impact factor:   1.228


  2 in total

Review 1.  Metastatic colorectal cancer-past, progress and future.

Authors:  Kathryn Field; Lara Lipton
Journal:  World J Gastroenterol       Date:  2007-07-28       Impact factor: 5.742

Review 2.  Paracetamol use during pregnancy - a call for precautionary action.

Authors:  Ann Z Bauer; Shanna H Swan; David Kriebel; Zeyan Liew; Hugh S Taylor; Carl-Gustaf Bornehag; Anderson M Andrade; Jørn Olsen; Rigmor H Jensen; Rod T Mitchell; Niels E Skakkebaek; Bernard Jégou; David M Kristensen
Journal:  Nat Rev Endocrinol       Date:  2021-09-23       Impact factor: 43.330

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.